<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1542959111536">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">23.11.2018 07:45:11 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.177dc8mby60bh</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>I work here &lt;a href=&quot;https://www.sarah-hyland.net/losartan-potassium-bladder-control-79a8.pdf&quot;&gt;losartan potasico 50 mg efectos secundarios&lt;/a&gt;  Vodafone was right to hold its nerve. The two companies are on the cusp of a deal at a price well over twice what Sarin would have got in 2006. But that is unlikely to be the end of the deal-making. Even if Vodafone gives half the proceeds to its shareholders and pays down its debt, it will have the firepower to gobble up more companies. The shrunken company could conceivably become a bid target itself, say for AT&amp;T. Given Vodafoneâs track record as a better seller than a buyer, its shareholders may well prefer that.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
